Hormone replacement therapy in relation to survival in women diagnosed with colon cancer

Cancer Causes and Control

Volumn 14, Issue 10, 2003, Pages 979-984

  Mandelson, Margaret T ^a,b,c   Miglioretti, Diana ^a   Newcomb, Polly A ^b   Harrison, Robert ^a   Potter, John D ^b  

^a CENTER FOR HEALTH STUDIES   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Colon cancer; Disease stage; Hormone replacement therapy; Prognosis; Survival

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; ASCENDING COLON; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL TRIAL; COHORT ANALYSIS; COLON CANCER; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DESCENDING COLON; FEMALE; HAZARD ASSESSMENT; HEALTH MAINTENANCE ORGANIZATION; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; PHARMACY; PRIORITY JOURNAL; RISK REDUCTION; UNITED STATES;

AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; WASHINGTON; WOMEN'S HEALTH;

EID: 0347720639     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CACO.0000007970.04094.76     Document Type: Article

References (28)

1. Potter JD (1993) Colon cancer - do the nutritional epidemiology, the gut physiology and the molecular biology tell the same story? J Nutr 123: 418-423.
2. Kampman E, Potter JD, Slattery ML, Caan BJ, Edwards S (1997) Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control 8(2): 146-158.
3. Gerhardsson de Verdier M, London S (1992) Reproductive factors, exogenous female hormones, and colorectal cancer by subsite. Cancer Causes Control 3: 355-360.
4. Furner SE, Davis FG, Nelson RL, Haenszel W (1989) A case-control study of large bowel cancer and hormone exposure in women. Cancer Res 49: 4936-4940.
5. Newcomb PA, Storer BE (1995) Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst 87: 1067-1071.
6. Jacobs EJ, White E, Weiss NS (1994) Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control 5: 359-366.
7. Chute CG, Willett WC, Colditz GA, Stampfer MJ, Rosner B, Speizer FE (1991) A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. Epidemiol 2: 201-207.
8. Folsom AR, Mink PJ, Sellers TA, Hong CP, Zheng W, Potter JD (1995) Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health 85: 1128-1132.
9. Fernandez E, Vechia CL, Braga C, et al. (1998) Hormone replacement therapy and risk of colon and rectal cancer. Ca Epidemiol Bio Prev 7: 329-333.
10. Grodstein F, Martinez ME, Platz EA, et al. (1998) Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med 128(9): 705-712.
11. Davis FG, Furner SE, Persky V, Koch M (1989) The influence of parity and exogenous female hormones on the risk of colorectal cancer. Int J Epidemiol 43: 587-590.
12. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results (2002) From the Women's Health Initiative randomized controlled trial. JAMA 288(3): 321-333. Notes: CORPORATE NAME: Writing Group for the Women's Health Initiative Investigators.
13. Slattery ML, Anderson K, Samowitz W, Edwards SL, Curtin K, Caan B, Potter JD (1999) Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer. Cancer Causes Control 10(5): 467-473.
14. Cox DR (1972) Regression models and life tables (with discussion). J Royal Stat Soc B(34): 86-94. Notes: per Diana Miglioretti.
15. Percy C, Van Holten V, Muir C, eds. (1990) International Classification of Diseases for Oncology, 2nd edn. Geneva: World Health Organization.
16. Psaty BM, Heckbert SR, Atkins D, et al. (1994) The risk of myocardialinfarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med 154: 1333-1339.
17. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285(2): 171-176.
18. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P (1996) Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 143: 971-978.
19. Barrett-Connor E (1995) Prevalence, initiation, and continuation of hormone replacement therapy. J Women's Health 4(2): 143-148.
20. McMichael AJ, Potter JD (1980) Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 65: 1201-1207.
21. Everson GT, McKinley C, Kern F Jr (1991) Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 87(1): 237-246.
22. Troisi R, Schairer C, Chow W, Schatzkin A, Brinton LA, Fraumeni JF Jr (1997) A prospective study of menopausal hormones and risk of colorectal cancer (United States). Cancer Causes Control 8: 130-138.
23. Slattery ML, Potter JD, Curtin K, et al. (2001) Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 61(1): 126-130.
24. Gryle R, Kim H, Hsieh ET, et al. (2000) Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342(2): 69-77.
25. Samowitz WS, Curtin K, Ma KN, et al. (2001) Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 10(9): 917-923.
26. Colditz GA (1998) Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst 90(11): 814-823.
27. Issa JPJ, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7: 536-540.
28. Breivik J, Lothe RA, Meling GI, Rognum TO, Borresen-Dale AL, Gaudernack G (1997) Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer 74(6): 664-669.